1036724-55-6

Basic information

• Product Name: 2-BENZYLOXY-1-BROMO-3-FLUOROBENZENE
• Synonyms: 2-BENZYLOXY-1-BROMO-3-FLUOROBENZENE
• CAS NO: 1036724-55-6
• Molecular Formula: C₁₃H₁₀BrFO
• Molecular Weight: 281.1203032
• Mol File: 1036724-55-6.mol
• Article Data: 4

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 2-BENZYLOXY-1-BROMO-3-FLUOROBENZENE(CAS DataBase Reference)
• NIST Chemistry Reference: 2-BENZYLOXY-1-BROMO-3-FLUOROBENZENE(1036724-55-6)
• EPA Substance Registry System: 2-BENZYLOXY-1-BROMO-3-FLUOROBENZENE(1036724-55-6)

Safety Data

• Hazardous Substances Data: 1036724-55-6(Hazardous Substances Data)

Upstream product

• 2040-89-3 2-bromo-6-fluorophenol 
• 100-44-7 benzyl chloride 
• 100-39-0 benzyl bromide 
• 38573-88-5 1-bromo-2,3-difluorobenzene 
• 100-51-6 benzyl alcohol 

Downstream Products

• 1152617-99-6 4-(3-fluoro-2-hydroxy-phenyl)-piperidine-1-carboxylic acid tert-butyl ester 
• 1152618-01-3 2-fluoro-6-piperidin-4-yl-phenol 
• 1376335-01-1 4-(2-benzyloxy-3-fluoro-phenyl)-1,2,3,6-tetrahydro-pyridine 
• 1376335-27-1 4-(3-fluoro-2-methoxy-phenyl)-piperidine-1-carboxylic acid tert-butyl ester 
• 1152617-96-3 4-(2-benzyloxy-3-fluoro-phenyl)-3,6-dihydro-2H-pyridine-1-carboxylic acid tert-butyl ester 

Relevant articles and documents

Novel structural negative liquid crystal monomer and preparation method

The invention belongs to the technical field of liquid crystal compounds, and particularly discloses a novel structural negative liquid crystal monomer shown in the structural formula (I). The monomercontains ethylene oxide and a fluorine-containing dibenzofuran negative dielectric anisotropy liquid crystal monomer. The monomer has good negative dielectric anisotropy, and preparation raw materials of the monomer are universal in the liquid crystal industry and are suitable for large-scale production.

RADIOLABELLED mGLuR2 PET LIGANDS

The present invention relates to novel, selective, radiolabelled mGluR2 ligands which are useful for imaging and quantifying the metabotropic glutamate receptor mGluR2 in tissues, using positron-emission tomography (PET). The invention is also directed to compositions comprising such compounds, to processes for preparing such compounds and compositions, to the use of such compounds and compositions for imaging a tissue, cells or a host, in vitro or in vivo and to precursors of said compounds.